# Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus II

> **NCT04890912** · NA · UNKNOWN · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 50 (estimated)

## Conditions studied

- Endometrial Cancer

## Interventions

- **RADIATION:** Conventional Fractionation
- **RADIATION:** Hypofractionation

## Key facts

- **NCT ID:** NCT04890912
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-15
- **Primary completion:** 2022-06-01
- **Final completion:** 2023-06-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-10-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04890912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04890912, "Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus II". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04890912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*